Treatment of older adults with acute promyelocytic leukaemia

Best Practice & Research Clinical Haematology - Tập 16 Số 3 - Trang 495-501 - 2003
Pierre Fenaux1, Sylvie Chevret2, Stéphane de Botton3
1Department of Hematology, Paris XIII University, France and Hôpital Avicenne, Bobigny 93000, France
2DBIM, Hôpital Saint Louis, Paris, France
3Dept of Hematology, Centre Hospitalier Universitaire, Lille, France;

Tóm tắt

Từ khóa


Tài liệu tham khảo

Fenaux, 2001, All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia, Seminars in Hematology, 38, 13, 10.1016/S0037-1963(01)90002-2

De Botton, 2003, Outcome of childhood acute promyelocytic leukemia (APL) with ATRA and chemotherapy: results on 31 cases, Journal of Clinical Oncology

Sanz, 1999, A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia, Blood, 94, 3015

Kanamaru, 1995, All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia, Blood, 85, 1202, 10.1182/blood.V85.5.1202.bloodjournal8551202

Tallman, 1997, All trans-retinoic acid in acute promyelocytic leukemia, New England Journal of Medicine, 337, 1021, 10.1056/NEJM199710093371501

Warrell, 1994, Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience, Leukemia, 8, 926

Sanz, 2000, Definition of relapse risk and rôle of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups, Blood, 96, 1247

Fenaux, 1999, A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia, Blood, 94, 1192, 10.1182/blood.V94.4.1192

De Botton, 1998, Incidence, clinical features, and outcome of all-trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia, Blood, 92, 2712, 10.1182/blood.V92.8.2712

Cunningham, 1989, Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital, Blood, 73, 1116, 10.1182/blood.V73.5.1116.1116

Head, 1994, Aggressive daunomycin (DNR) therapy improves survival in acute promyelocytic leukemia (APL), a Southwest Oncology Group (SWOG) trial, Leukemia, 8, S38

Fenaux, 1991, Treatment of acute promyelocytic leukemia: a report on 70 cases, Leukemia and Lymphoma, 4, 249, 10.3109/10428199109068072

Burnett, 1999, Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC Trial, Blood, 93, 4131, 10.1182/blood.V93.12.4131

Thomas, 2000, Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation, Leukemia, 14, 1006, 10.1038/sj.leu.2401800

Soignet, 2001, United States multicenter study or arsenic trioxide in relapsed acute promyelocytic leukemia, Journal of Clinical Oncology, 18, 3852, 10.1200/JCO.2001.19.18.3852

Shen, 1997, Use of arsenic trioxide (AS2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients, Blood, 89, 3354, 10.1182/blood.V89.9.3354

Niu, 1999, Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients, Blood, 94, 3315, 10.1182/blood.V94.10.3315.422k16_3315_3324

Hu, 1999, Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and AS2O3: an experience of 120 patients at a single institution, International Journal of Hematology, 70, 248

Sanz, 2000, All-trans retinoic acid and low-dose chemotherapy for acute promyelocytic leukaemia, British Journal of Haematology, 109, 896, 10.1046/j.1365-2141.2000.109004896.x

Estey, 1997, Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine, Journal of Clinical Oncology, 15, 3021, 10.1200/JCO.1997.15.2.483

Avvisati, 2002, Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized sutdy LAP 0389 with 7 years of minimal follow-up, Blood, 100, 3141, 10.1182/blood-2002-02-0352

Latagliata, 1997, The role of all-trans-retinoic acid (ATRA) treatment in newly-diagnosed acute promyelocytic leukemia patients aged >60 years, Annals of Oncology, 8, 1273, 10.1023/A:1008272817839

Lu, 2002, Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report, Blood, 99, 3136, 10.1182/blood.V99.9.3136

Jing, 2001, Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo, Blood, 97, 264, 10.1182/blood.V97.1.264